Bristol-Myers Squibb Company et al v. Dr. Reddys Laboratories, Ltd. et al
Pfizer Inc. and Bristol-Myers Squibb Company |
Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd. |
1:2017cv00401 |
April 10, 2017 |
US District Court for the District of Delaware |
Wilmington Office |
New Castle |
Leonard P Stark |
Patent |
35 U.S.C. § 271 |
None |
Docket Report
This docket was last retrieved on November 14, 2017. A more recent docket listing may be available from PACER.
Document Text |
---|
Case associated with lead case: Create association to 1:17-cv-00374-LPS. (ntl) |
ORAL ORDER: In light of the District Court's ADR referral in this case, and the number of parties involved in this matter and related cases, the Court orders as follows: Plaintiff(s) counsel shall contact counsel for each defendant to discuss whether both sides believe that the Court's assistance with settlement discussions would be helpful at some point in the case. If both plaintiff(s) and an individual defendant believe that the case has reached a stage whereby the Court's assistance is needed with regard to settlement, plaintiff(s) counsel shall contact the Court to schedule an ADR Teleconference for plaintiff and that individual defendant. Ordered by Judge Christopher J. Burke on 11/3/2017. Associated Cases: 1:17-cv-00374-LPS et al.(dlb) |
CASE REFERRED to Magistrate Judge Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at # http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:17-cv-00374-LPS et al.(dlb) |
Filing 20 SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. These actions are CONSOLIDATED for purposes of discovery and all papers shall be filed in Civil Action No. 17-374-LPS. Discovery due by 7/12/2019. Status Report due by 11/30/2018. Claim Construction Opening Brief due by 6/22/2018. Claim Construction Answering Brief due by 7/27/2018. A Markman Hearing is set for 9/4/2018 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark. Proposed Pretrial Order due by 9/20/2019. A Final Pretrial Conference is set for 9/27/2019 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark. A Bench Trial (at least 5 days) is set for 10/15/2019 at 08:30 AM in Courtroom 6B before Judge Leonard P. Stark. Signed by Judge Leonard P. Stark on 11/2/17. Associated Cases: 1:17-cv-00374-LPS et al. (ntl) |
Filing 19 NOTICE OF SERVICE of (i) Plaintiffs' First Set of Common Requests for Production of Documents and Things and (ii) Plaintiffs' First Set of Common Interrogatories filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) |
Filing 18 NOTICE OF SERVICE of Plaintiffs' Fed. R. Civ. P. 26(a)(1) Initial Disclosures filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) |
Filing 17 NOTICE OF SERVICE of Defendants' Fed. R. Civ. P. 26(a)(1) Initial Disclosures filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(O'Byrne, Stephanie) |
Filing 16 PROPOSED ORDER Proposed Scheduling Order by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: #1 Letter to The Honorable Leonard P. Stark)(Farnan, Michael) |
Filing 15 ORAL ORDER: IT IS HEREBY ORDERED that the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposal, including a proposal for the length and timing of trial, to the Court no later than September 22, 2017. The parties are to review the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Stark, New Patent Procedures). ORDERED by Judge Leonard P. Stark on 8/31/17. Associated Cases: 1:17-cv-00374-LPS et al. (ntl) |
Pro Hac Vice Attorney Nina Vachhani,Carolyn A. Blessing,David B. Abramowitz,Michael J. Gaertner,Keith D. Parr for Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) |
SO ORDERED, re #14 MOTION for Pro Hac Vice Appearance of Attorney Keith D. Parr, Michael J. Gaertner, David B. Abramowitz, Carolyn A. Blessing, and Nina Vachhani of Locke Lord LLP filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd. Signed by Judge Leonard P. Stark on 8/2/17. (ntl) |
Filing 14 MOTION for Pro Hac Vice Appearance of Attorney Keith D. Parr, Michael J. Gaertner, David B. Abramowitz, Carolyn A. Blessing, and Nina Vachhani of Locke Lord LLP - filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Palapura, Bindu) |
Filing 13 ANSWER to #11 Answer to Complaint, Counterclaim by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) |
Filing 12 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Dr. Reddy's Laboratories, Ltd. for Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd. filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Moore, David) |
Filing 11 ANSWER to #1 Complaint, Defenses, and, COUNTERCLAIM against Bristol-Myers Squibb Company, Pfizer Inc. by Dr. Reddys Laboratories, Ltd., Dr. Reddys Laboratories, Inc..(Moore, David) |
SO ORDERED, re #10 STIPULATION TO EXTEND TIME to answer or otherwise respond to the Complaint to July 7, 2017 filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd. Signed by Judge Leonard P. Stark on 6/14/17. (ntl) |
Filing 10 STIPULATION TO EXTEND TIME to answer or otherwise respond to the Complaint to July 7, 2017 - filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (O'Byrne, Stephanie) |
Pro Hac Vice Attorney Andrew J. Danford for Bristol-Myers Squibb Company added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:17-cv-00412-LPS et al.(crb) |
Pro Hac Vice Attorney Heather M. Petruzzi for Bristol-Myers Squibb Company added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:17-cv-00375-LPS et al.(crb) |
Pro Hac Vice Attorney Kevin M. Yurkerwich for Bristol-Myers Squibb Company added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:17-cv-00377-LPS et al.(crb) |
Pro Hac Vice Attorney Timothy Cook for Bristol-Myers Squibb Company added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) |
Pro Hac Vice Attorney Jeffrey T. Hantson for Bristol-Myers Squibb Company added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:17-cv-00374-LPS et al.(crb) |
Pro Hac Vice Attorney Tracey C. Allen for Bristol-Myers Squibb Company added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:17-cv-00375-LPS et al.(dmp, ) |
Pro Hac Vice Attorney Amy K. Wigmore for Bristol-Myers Squibb Company added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:17-cv-00375-LPS et al.(crb) |
SO ORDERED, re (8 in 1:17-cv-00408-LPS, 9 in 1:17-cv-00374-LPS, 7 in 1:17-cv-00378-LPS, 8 in 1:17-cv-00412-LPS, 9 in 1:17-cv-00409-LPS, 9 in 1:17-cv-00404-LPS, 8 in 1:17-cv-00382-LPS, 9 in 1:17-cv-00403-LPS, 8 in 1:17-cv-00376-LPS, 8 in 1:17-cv-00381-LPS, 8 in 1:17-cv-00407-LPS, 10 in 1:17-cv-00411-LPS, 8 in 1:17-cv-00380-LPS, 7 in 1:17-cv-00405-LPS, 10 in 1:17-cv-00410-LPS, 8 in 1:17-cv-00398-LPS, 7 in 1:17-cv-00399-LPS, 8 in 1:17-cv-00400-LPS, 8 in 1:17-cv-00426-LPS, 7 in 1:17-cv-00375-LPS, 8 in 1:17-cv-00406-LPS, 10 in 1:17-cv-00377-LPS, 9 in 1:17-cv-00379-LPS, 9 in 1:17-cv-00401-LPS, 8 in 1:17-cv-00402-LPS) MOTION for Pro Hac Vice Appearance of Attorney Amy K. Wigmore, Gregory H. Lantier, Tracey C. Allen, Heather M. Petruzzi, Andrew J. Danford, Jeffrey T. Hantson, Timothy A. Cook, and Kevin M. Yurkerwich filed by Pfizer Inc., Bristol-Myers Squibb Company. Signed by Judge Leonard P. Stark on 5/5/17. Associated Cases: 1:17-cv-00374-LPS et al. (ntl) |
Filing 9 MOTION for Pro Hac Vice Appearance of Attorney Amy K. Wigmore, Gregory H. Lantier, Tracey C. Allen, Heather M. Petruzzi, Andrew J. Danford, Jeffrey T. Hantson, Timothy A. Cook, and Kevin M. Yurkerwich - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) |
SO ORDERED, re #8 STIPULATION TO EXTEND TIME to answer or otherwise respond to the Complaint to June 19, 2017 filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd. Signed by Judge Leonard P. Stark on 5/1/17. (ntl) |
Filing 8 STIPULATION TO EXTEND TIME to answer or otherwise respond to the Complaint to June 19, 2017 - filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Moore, David) |
Filing 7 SUMMONS Returned Executed by Bristol-Myers Squibb Company, Pfizer Inc.. Dr. Reddys Laboratories, Inc. served on 4/13/2017, answer due 5/4/2017; Dr. Reddys Laboratories, Ltd. served on 4/13/2017, answer due 5/4/2017. (Farnan, Michael) |
Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:17-cv-00374-LPS through 1:17-cv-00382-LPS and 1:17-cv-00398-LPS through 1:17-cv-00412-LPS (rjb) |
Summons Issued with Magistrate Consent Notice attached as to Dr. Reddys Laboratories, Inc. on 4/11/2017; Dr. Reddys Laboratories, Ltd. on 4/11/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (ceg) |
Filing 6 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Pfizer Inc. (ceg) |
Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Bristol-Myers Squibb Company. (ceg) |
Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,326,945 B2. (ceg) |
Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 3/10/2017. Date of Expiration of Patent: 2/24/2031.Thirty Month Stay Deadline: 6/28/2020. (ceg) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) |
Filing 1 COMPLAINT for PATENT INFRINGEMENT filed against Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2119479.) - filed by Bristol-Myers Squibb Company, Pfizer Inc. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Civil Cover Sheet)(ceg) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.